Vetoquinol is one of the main international players in animal health for livestock and pets. We’re an independent company, solely focused on innovating, developing, producing, and marketing veterinary drugs and non-medicinal products globally.
In 2022, our organisation registered a sales revenue of €540 million. This was from 24 countries with equal amounts coming from farm animals and pets. it was all thanks to our established network of over 60 partner distributors.
Since our creation in 1933, Vetoquinol has combined innovation and geographical diversification. The strengthening of our product portfolio – and various acquisitions – has ensured growth for our group. Today, Vetoquinol employs more than 2,500 people.
Vetoquinol’s key figures for 2022:
|2022 turnover: € 540 million
Essential* products turnover: € 304 million
|Breakdown of group turnover by activity:
* Vetoquinol key products.